Scholarlink

Background <p>Pathogenic variants involving the transcription factor <i>TBX4</i> gene have been associated with various skeletal and pulmonary abnormalities, including lethal lung developmental disorders (LLDD).</p> Methods <p>Whole-genome sequencing (WGS) with AI-powered platform for variant detection and interpretation followed by Sanger sequencing targeted variant segregation analysis were used. Reverse transcription quantitative PCR (RT-qPCR) and immunohistochemistry (IHC) studies were performed to assess gene and protein expression levels, respectively.</p> Results <p>We describe two unrelated families with intrafamilial variability in the <i>TBX4</i> phenotypic expressivity, including LLDDs. WGS analyses revealed two frameshift variants, c.1019del; p.(Arg340GlnfsTer40) in the penultimate exon and c.1167dup; p.(Arg390GlnfsTer30) in the last exon of <i>TBX4</i>, both predicted to escape nonsense mediated mRNA decay (NMD) and associated with highly variable phenotypes. RT-qPCR and IHC studies implied incomplete NMD in one family.</p> Conclusions <p>Our data expand the phenotypic and genotypic landscape of <i>TBX4</i>–associated pulmonary disease to include asthma. We propose incompleteness and variability of NMD escape contributing to the observed wide phenotypic spectrum and increased risk of LLDDs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Inherited TBX4 frameshifting variants predicted to escape nonsense mediated decay in two families with variable phenotypes, including lethal lung developmental disorders

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Shruti A. Pande,
  • Hiuling Chan Joiner,
  • Przemyslaw Szafranski,
  • Tomasz Gambin,
  • Michelle Wright,
  • Qian Wang,
  • Maiah Walters,
  • Jan M. Friedman,
  • Jessica Saunders,
  • Nicholas Avdimiretz,
  • Cornelius F. Boerkoel,
  • Nahir Cortes-Santiago,
  • Gail Deutsch,
  • Pawel Stankiewicz

摘要

Background

Pathogenic variants involving the transcription factor TBX4 gene have been associated with various skeletal and pulmonary abnormalities, including lethal lung developmental disorders (LLDD).

Methods

Whole-genome sequencing (WGS) with AI-powered platform for variant detection and interpretation followed by Sanger sequencing targeted variant segregation analysis were used. Reverse transcription quantitative PCR (RT-qPCR) and immunohistochemistry (IHC) studies were performed to assess gene and protein expression levels, respectively.

Results

We describe two unrelated families with intrafamilial variability in the TBX4 phenotypic expressivity, including LLDDs. WGS analyses revealed two frameshift variants, c.1019del; p.(Arg340GlnfsTer40) in the penultimate exon and c.1167dup; p.(Arg390GlnfsTer30) in the last exon of TBX4, both predicted to escape nonsense mediated mRNA decay (NMD) and associated with highly variable phenotypes. RT-qPCR and IHC studies implied incomplete NMD in one family.

Conclusions

Our data expand the phenotypic and genotypic landscape of TBX4–associated pulmonary disease to include asthma. We propose incompleteness and variability of NMD escape contributing to the observed wide phenotypic spectrum and increased risk of LLDDs.